Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients
Keyword(s):
B Cell
◽
Abstract Ibrutinib is an oral first-in-class Bruton’s tyrosine kinase inhibitor approved for the therapy of various B-cell lymphoid malignancies. Among ibrutinib-related infections, viral hepatitis are poorly described. We report our single-center experience with 4 cases of chronic hepatitis E virus infection and their management with ribavirin.
2012 ◽
Vol 16
(7)
◽
pp. 742-747
◽
2020 ◽
Vol 44
(2)
◽
pp. 174-180
Keyword(s):
2020 ◽
Vol 10
(2)
◽
pp. 135-138
◽
Keyword(s):
2017 ◽
Vol 88
◽
pp. 39-45
◽
2020 ◽
Vol 52
(8)
◽
pp. 926-927
◽
2020 ◽
Vol 104
(2)
◽
pp. 437-444
◽
Keyword(s):
2019 ◽
Vol 23
(1)
◽
pp. 45-52
◽
Keyword(s):